(redirected from P-glycoprotein)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to P-glycoprotein: ABCB1
PGPPretty Good Privacy
PGPPost Graduate Programme (India)
PGPPhysician Group Practice (Medicare)
PGPPelvic Girdle Pain
PGPPersonal Genome Project (Harvard Medical School)
PGPProtein Gene Product (pathology)
PGPProgram Parameters
PGPPaternal Grandparent (various organizations)
PGPPhysics of Geological Processes
PGPPassword Generator Protocol
PGPPretty Good Protection (encryption)
PGPPresentation of Grouped Procedures (medical imaging)
PGPPearl of Great Price
PGPProgram Parameter (File Name Extension)
PGPProcter & Gamble Pharmaceuticals, Inc.
PGPProcter & Gamble Productions
PGPPhosphorylated Glycoprotein (biology)
PGPPersonal Growth Plan
PGPPfizer Global Pharmaceuticals
PGPPayment Gateway Provider (electronic commerce)
PGPPre Game Poop
PGPPower Generation Plant (various locations)
PGPPro-Gun Progressive (politics)
PGPPreemptive Goal Programming
PGPPower Generation Platform
PGPPreferred Gender Pronoun (liguistics)
PGPPast Grand Patriarch (IOOF)
PGPProcedures Generation Package
PGPPrivate Generating Plant
PGPFundación Pequeñas Grandes Personas (Little People of Chile)
PGPPerforated Ground Plane
PGPPrevious Glacial Period
PGPProtected Gold Participation Unit
PGPPretty Good Pigeons
PGPParti Gabonaise du Progres (Gabonese Party for Progress)
References in periodicals archive ?
Also with warfarin; inhibits OCT2 and Torsades de pointes P-glycoprotein has occurred when given with some antiarrhythmics; bradycardia may occur when used with beta-blockers and calcium channel blockers.
Piperine has been shown to increase small intestine absorption surfaces and inhibit intestinal P-glycoprotein
Functional interactions between P-glycoprotein and CYP3A in drug metabolism.
They dont get in, because of P-glycoprotein, but this same protector also keeps out helpful therapeutics.
Conclusion: Proton pump inhibitors may alter P-glycoprotein expression in the gastrointestinal tract, and subsequently H.
This drug is recognized and transported by P-glycoprotein (P-gp) a drug transporter encoded by adenosine triphosphate-binding cassette subfamily B member 1 (ABCB1) in the blood brain barrier.
Ji, "BME, a novel compound of anthraquinone, down regulated P-glycoprotein expression in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells via generation of reactive oxygen species," Chemico-Biological Interactions, vol.
This P-glycoprotein and CYP3A inhibition by cannabinoids brings up the possibility for drug interactions and potential toxicity, particularly at a time of expanding medical marijuana laws throughout the country.
However, ABCB1 is highly polymorphic; the polymorphism of which may affect the expression and function of P-glycoprotein (P-gp) and thus can influence the drug disposition in the CNS, affecting efficacy and treatment outcomes.
a) Avoid coadministration of P-glycoprotein inducers.